At Pacific Presbyterian Medical Center endomyocardial biopsies are utilized in pediatric oncology patients to evaluate the degree of cardiotoxicity resulting from the anthracycline agents doxorubicin and daunorubicin. This article discusses the indications, technical aspects, potential risks and complications of endomyocardial biopsy in pediatric oncology patients. The nursing care of the pediatric patient and family, as well as age-specific teaching guidelines, are described.
Get full access to this article
View all access options for this article.
References
1.
Von Hoff, D.D. , et al. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med.91:5:710-717, November, 1979.
2.
Pratt, C.B., Ransom, J.L., and Evans, M.E.Age-related adriamycin cardiotoxicity in children. Cancer Treat. Rep.62:9:1381-1384, September, 1978.
3.
Von Hoff, D.D. , et al. Daunomycin-induced cardiotoxicity in children and adults. Am. J. Med.62:2:200-208, February, 1977.
4.
Bristow, M.R.Toxic cardiomyopathy due to doxorubicin. Hosp. Pract.17:12:101-111, December, 1982.
5.
Ferrans, V.G.Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat. Rep.62:6:955-961, June, 1978.
6.
Billingham, M.E., et al. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat. Rep.62:6:865-872, June, 1978.
7.
Bristow, M.R. , et al. Doxorubicin cardiomyopathy: Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann. Intern. Med.88:2:168-175, February, 1978.
8.
Legha, S.S., et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann. Intern. Med.96:2:133-139, February, 1982.
9.
Druek, M.R., et al. Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity. Cancer53:8:1667-1674, April 15, 1984.
10.
Kennedy, J.W. , et al. Radionuclide angiography for the evaluation of anthracycline therapy. Cancer Treat. Rep.62:6:941-943, June, 1978.
11.
Moodie, D.S. , et al. Serial assessment of doxorubicin cardiotoxicity in pediatric patients with quantitative radionuclide angiocardiography. Cleve. Clin. Q.47:4: 327-331, Winter, 1980.
12.
Mason, J.W.Techniques for right and left ventricular endomyocardial biopsy. Am. J. Cardiol.41:5:887-892, May 1, 1978.
13.
Bristow, M.R. , et al. Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer50:1:32-41, July 1, 1982.
14.
Pegelow, C.H. , et al. Endomyocardial biopsy to monitor anthracycline therapy in children. J. Clin. Oncol.2:5:443-446, May, 1984 .
15.
Mason, J.W. , et al. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: Superiority of - histopathologic assessment using endomyocardial biopsy. Cancer Treat. Rep.62:6: 857-864, June, 1978.
